Research output per year
Research output per year
Fingerprint
Dive into the research topics where Wietse Geens is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
A phase I trial on the intra- and post-operative intracranial administration of ipilimumab and nivolumab in patients with recurrent high-grade glioma.
Neyns, B., Dirven, I., Lescrauwaet, L., Del'haye, J. J. C., Geens, W., Geeraerts, X. & Stevens, L., 1 Jun 2024, In: Journal of Clinical Oncology. 42, 16, 1 p., 2037.Research output: Contribution to journal › Meeting abstract (Journal)
Open AccessFile -
Enhacing brain tumor border detection through navigated intraoperative ultrasound imaging
Lescrauwaet, L., Van Gestel, F., Geens, W., Ibis, K. A., Vlaes, B., Bruneau, M. & Duerinck, J., 19 Apr 2024.Research output: Unpublished contribution to conference › Poster
-
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-Guided Analysis
Arrieta, V. A., Duerinck, J., Burdett, K. B., Habashy, K. J., Geens, W., Gould, A., Schwarze, J. K., Dmello, C., Kim, K-S., Saganty, R., Chen, L., Moscona, A., McCord, M., Lee-Chang, C., Horbinski, C. M., Zhang, H., Stupp, R., Neyns, B. & Sonabend, A. M., 15 Jan 2024, In: Clinical Cancer Research. 30, 2, p. 379-388 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Citations (Scopus)141 Downloads (Pure) -
From bleeding to diagnosis : unveiling a case of epithelioid hemangioendothelioma
Vannerom, C. G., Geens, W., Marcelis, W., Van Gestel, F., Van der Straeten, R., van Tussenbroek, F., Brock, S., Duerinck, J. & Bruneau, M., 19 Apr 2024.Research output: Unpublished contribution to conference › Poster
-
Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition
Geens, W., Vanlaer, N., Nijland, L., Van Laere, S., Schwarze, J. K., Bruneau, M., Neyns, B., Rogiers, A. & Duerinck, J., 2024, In: Journal of Neuro-Oncology. 168, 1, p. 159-169 11 p.Research output: Contribution to journal › Article › peer-review
Activities
- 4 Talk or presentation at a conference
-
Prognostic value of 0-(2-[18F]-fluoroethyl)-L-tyrosine PET in patients with recurrent glioblastoma.
Wietse Geens (Speaker), Stephanie Du Four (Contributor), S VAN LAERE (Contributor), Julia Katharina Schwarze (Contributor), Gil Awada (Contributor), Michaël Bruneau (Contributor), Jens Tijtgat (Contributor), Hendrik Everaert (Contributor), Bart Neyns (Contributor) & Johnny Duerinck (Contributor)
26 Mar 2022Activity: Talk or presentation › Talk or presentation at a conference
-
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
Wietse Geens (Speaker), Julia Katharina Schwarze (Contributor), Cleo Bertels (Contributor), Jens Tijtgat (Contributor), Gil Awada (Contributor), F Vaeyens (Contributor), Louise Cras (Contributor), Anne Vanbinst (Contributor), Hendrik Everaert (Contributor), Alex Michotte (Contributor), Toon Janssen (Contributor), Ben Caljon (Contributor), Thomas Cauwenbergh (Contributor), Michaël Bruneau (Contributor), Ramses Forsyth (Contributor), Sandra Tuyaerts (Contributor), Bart Neyns (Contributor) & Johnny Duerinck (Contributor)
26 Mar 2022Activity: Talk or presentation › Talk or presentation at a conference
-
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
Wietse Geens (Speaker), Julia Katharina Schwarze (Contributor), Cleo Bertels (Contributor), Jens Tijtgat (Contributor), Gil Awada (Contributor), F Vaeyens (Contributor), Louise Cras (Contributor), Anne Vanbinst (Contributor), Hendrik Everaert (Contributor), Alex Michotte (Contributor), Toon Janssen (Contributor), Ben Caljon (Contributor), Thomas Cauwenbergh (Contributor), Michaël Bruneau (Contributor), Ramses Forsyth (Contributor) & Bart Neyns (Contributor)
26 Mar 2022Activity: Talk or presentation › Talk or presentation at a conference
-
Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): a multi-cohort adaptive phase I clinical trial
Julia Katharina Schwarze (Speaker), Wietse Geens (Contributor), Jens Tijtgat (Contributor), Gil Awada (Contributor), Anne-Marie Van Binst (Contributor), Hendrik Everaert (Contributor), Laura Seynaeve (Contributor), Alex Michotte (Contributor), Michaël Bruneau (Contributor), I VAN RIET (Contributor), Sandra Tuyaerts (Contributor), Johnny Duerinck (Contributor) & Bart Neyns (Contributor)
16 Sep 2021 → 21 Sep 2021Activity: Talk or presentation › Talk or presentation at a conference